Followers | 17 |
Posts | 2756 |
Boards Moderated | 0 |
Alias Born | 02/20/2011 |
Thursday, February 26, 2015 6:02:04 AM
A customer hub for marking, validation and authentication processes
STONY BROOK, NY, February 26, 2015. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today the expansion of its digitalDNA® software and services platform to enable customers' business process controls and supply chain partner collaboration throughout the entire lifecycle of marking, validating and authenticating goods. The new features enhance the foundation of bar code item tracking layered with SigNature® DNA as the forensic backstop.
New features on the secure cloud application include DNA custody management, forensic sample submission, CODA (certificate of DNA authentication) issuance, customer account administration, order placement, status tracking and reporting, and online training. Scanning bar code item numbers on marked goods enables individuals to post or access information about a product such as its geo-location, original image or associated documentation. Consumers may take advantage of marketing information supplied by brand owners.
The system is operational and has managed the marking and authentications processes for over 40,000 electronics parts. Market-specific configurations have been demonstrated to businesses in textiles supply chain, printing/publishing, art and collectibles and law enforcement.
The cloud-based platform is designed to be customizable for the particular attributes of each customer's business and operates either as a stand-alone system or interfaced to an enterprise business system or other third-party platform. It conforms to strict security standards for ISO, PCI, and Federal Information Processing Standards.
This digitalDNA platform is designed as the data management and reporting hub for APDN's recently announced devices for DNA on-site authentication and optical mark in-field validation. In addition, using standard software and development tools, the system supports APDN-certified third-party devices such as InData Systems' covert "invisible bar code" scanning, and any browser-based enterprise or consumer devices such as mobile computers, smartphones and tablets.
Judy Murrah, APDN's CIO, comments that, "The expansion of our digitalDNA platform enhances the value of APDN's customer engagement by offering chain of custody visibility, supply chain quality and process control reporting, consumer confidence for brand owners and a seamless connection for our in-lab, in-field and on-site authentication and validation systems. A new business model of consulting services, software and device sales and other customer services is emerging for APDN."
"Our IT roadmap is now paralleling the content-service capacity of DNA. This platform sets the stage for APDN's next steps in the revolutionary integration of rich biotechnology-generated information and the information technology delivery systems within which they reside," said Dr. James Hayward, APDN's President and CEO."
Recent APDN News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2024 10:18:33 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 09:25:36 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/12/2024 09:09:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:01:31 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/01/2024 09:05:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:24:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/10/2024 10:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/07/2023 09:01:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 10:09:34 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/07/2023 10:02:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:01:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 08:02:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:04:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM